<http://webisa.webdatacommons.org/136764127>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/135508721>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/136764127> .
<http://webisa.webdatacommons.org/prov/160711776>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/136764127> .
<http://webisa.webdatacommons.org/prov/135933191>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/136764127> .
<http://webisa.webdatacommons.org/136764127>	<http://www.w3.org/ns/prov#value>	"CNSE) and Pittsfield, Massachusetts-based Nuclea Biotechnologies, Inc. (Nuclea) today announced the launch of a $1 million research partnership to enable the development and commercialization of a high-throughput nanochip to accelerate the diagnosis and treatment of breast, colon, prostate and other cancers." .
<http://webisa.webdatacommons.org/136764127>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<kooperation-international.de> .
<http://webisa.webdatacommons.org/prov/483117016>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/136764127> .